UBX0101
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Osteoarthritis, Knee
Conditions
Osteoarthritis, Knee
Trial Timeline
Oct 30, 2019 → Aug 7, 2020
NCT ID
NCT04129944About UBX0101
UBX0101 is a phase 2 stage product being developed by Unity Biotechnology for Osteoarthritis, Knee. The current trial status is completed. This product is registered under clinical trial identifier NCT04129944. Target conditions include Osteoarthritis, Knee.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04229225 | Phase 1 | Completed |
| NCT04129944 | Phase 2 | Completed |
| NCT03513016 | Phase 1 | Completed |
Competing Products
20 competing products in Osteoarthritis, Knee